nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Aminosalicylic Acid—PTGS2—bone cancer	0.033	0.445	CrCbGaD
Droxidopa—Mesalazine—PTGS2—bone cancer	0.0259	0.349	CrCbGaD
Droxidopa—Epinephrine—CYP3A4—bone cancer	0.0152	0.205	CrCbGaD
Droxidopa—DDC—Metabolism—DHFR—bone cancer	0.00162	0.00175	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—SMO—bone cancer	0.00161	0.00174	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—RGS1—bone cancer	0.0016	0.00173	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—GRM4—bone cancer	0.0016	0.00173	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—GRM1—bone cancer	0.00159	0.00172	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—IL3—bone cancer	0.00157	0.0017	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—GRM1—bone cancer	0.00156	0.00169	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—GRM1—bone cancer	0.00156	0.00168	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—GRM1—bone cancer	0.00155	0.00168	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—GRM1—bone cancer	0.00154	0.00167	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL3—bone cancer	0.00153	0.00166	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—GRM1—bone cancer	0.00153	0.00165	CbGpPWpGaD
Droxidopa—DDC—Metabolism—GNA11—bone cancer	0.00151	0.00163	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—RGS1—bone cancer	0.00149	0.00161	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—GRM4—bone cancer	0.00149	0.00161	CbGpPWpGaD
Droxidopa—PAH—Disease—KIT—bone cancer	0.00148	0.0016	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—IL3—bone cancer	0.00147	0.00159	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—RGS1—bone cancer	0.00146	0.00157	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—GRM4—bone cancer	0.00146	0.00157	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—GRM1—bone cancer	0.00144	0.00156	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—SPARC—bone cancer	0.00144	0.00155	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—GRM1—bone cancer	0.00142	0.00153	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—NT5C3A—bone cancer	0.00141	0.00152	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	0.00139	0.0015	CbGpPWpGaD
Droxidopa—PAH—Disease—BRAF—bone cancer	0.00139	0.0015	CbGpPWpGaD
Droxidopa—DDC—Metabolism—CYP3A4—bone cancer	0.00137	0.00148	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—RGS1—bone cancer	0.00135	0.00146	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—GRM4—bone cancer	0.00135	0.00146	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—GNA11—bone cancer	0.00132	0.00142	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—GRM1—bone cancer	0.00129	0.00139	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—GRM1—bone cancer	0.00126	0.00136	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—GNA11—bone cancer	0.00121	0.00131	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—SMO—bone cancer	0.00121	0.0013	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IL3—bone cancer	0.00119	0.00129	CbGpPWpGaD
Droxidopa—DDC—Metabolism—GSTP1—bone cancer	0.00117	0.00127	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—GRM1—bone cancer	0.00117	0.00127	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GRM4—bone cancer	0.00117	0.00126	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RGS1—bone cancer	0.00117	0.00126	CbGpPWpGaD
Droxidopa—PAH—Disease—MDM2—bone cancer	0.00116	0.00126	CbGpPWpGaD
Droxidopa—PAH—Disease—PTGS2—bone cancer	0.00112	0.00121	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—GNA11—bone cancer	0.00111	0.00119	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—GNA11—bone cancer	0.0011	0.00119	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—IL3—bone cancer	0.0011	0.00119	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—SMO—bone cancer	0.0011	0.00119	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—GNA11—bone cancer	0.0011	0.00118	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SMO—bone cancer	0.00109	0.00118	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—SMO—bone cancer	0.00109	0.00118	CbGpPWpGaD
Droxidopa—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.00109	0.00117	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—GNA11—bone cancer	0.00108	0.00117	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—SMO—bone cancer	0.00107	0.00116	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GRM4—bone cancer	0.00106	0.00115	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RGS1—bone cancer	0.00106	0.00115	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RGS1—bone cancer	0.00105	0.00114	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GRM4—bone cancer	0.00105	0.00114	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GRM4—bone cancer	0.00104	0.00112	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RGS1—bone cancer	0.00104	0.00112	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—PLAU—bone cancer	0.00103	0.00111	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—GNA11—bone cancer	0.00102	0.00111	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—SMO—bone cancer	0.00102	0.0011	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GRM1—bone cancer	0.00101	0.00109	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—GNA11—bone cancer	0.00101	0.00109	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—GNA11—bone cancer	0.001	0.00109	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—IL3—bone cancer	0.001	0.00108	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—SMO—bone cancer	0.001	0.00108	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—GNA11—bone cancer	0.001	0.00108	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL3—bone cancer	0.001	0.00108	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—GNA11—bone cancer	0.000996	0.00108	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—IL3—bone cancer	0.000994	0.00107	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GRM4—bone cancer	0.000983	0.00106	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RGS1—bone cancer	0.000983	0.00106	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—GNA11—bone cancer	0.000983	0.00106	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—IL3—bone cancer	0.000981	0.00106	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GRM4—bone cancer	0.000968	0.00105	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RGS1—bone cancer	0.000968	0.00105	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—PLAU—bone cancer	0.000964	0.00104	CbGpPWpGaD
Droxidopa—PAH—Metabolism—PTGS2—bone cancer	0.000939	0.00101	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—GNA11—bone cancer	0.00093	0.001	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ATF1—bone cancer	0.00093	0.001	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—IL3—bone cancer	0.000928	0.001	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GRM1—bone cancer	0.000921	0.000995	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—GNA11—bone cancer	0.000915	0.000988	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—IL3—bone cancer	0.000914	0.000987	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GRM1—bone cancer	0.000913	0.000986	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL3—bone cancer	0.000911	0.000984	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL3—bone cancer	0.000907	0.000979	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL3—bone cancer	0.000903	0.000975	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GRM1—bone cancer	0.000901	0.000973	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000901	0.000973	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	0.000895	0.000967	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL3—bone cancer	0.000891	0.000962	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—SMO—bone cancer	0.000889	0.00096	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GRM4—bone cancer	0.00086	0.000928	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RGS1—bone cancer	0.00086	0.000928	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GRM1—bone cancer	0.000852	0.000921	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL3—bone cancer	0.000843	0.000911	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GRM1—bone cancer	0.000839	0.000906	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	0.000832	0.000898	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL3—bone cancer	0.00083	0.000896	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—SMO—bone cancer	0.000826	0.000892	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—GNA11—bone cancer	0.000813	0.000878	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL3—bone cancer	0.000812	0.000877	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.0008	0.000864	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GRM4—bone cancer	0.000799	0.000863	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RGS1—bone cancer	0.000799	0.000863	CbGpPWpGaD
Droxidopa—PAH—Disease—EGFR—bone cancer	0.000795	0.000858	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—PLAU—bone cancer	0.000783	0.000845	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFBR2—bone cancer	0.000775	0.000837	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ENO2—bone cancer	0.000758	0.000818	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—GNA11—bone cancer	0.000755	0.000816	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL3—bone cancer	0.000754	0.000814	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GRM1—bone cancer	0.000745	0.000805	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL3—bone cancer	0.000737	0.000796	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IGF1R—bone cancer	0.000729	0.000788	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SMO—bone cancer	0.000712	0.000769	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—DHFR—bone cancer	0.000703	0.000759	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GRM1—bone cancer	0.000692	0.000748	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL3—bone cancer	0.000685	0.00074	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GNA11—bone cancer	0.000657	0.00071	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GNA11—bone cancer	0.000651	0.000704	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SMO—bone cancer	0.000649	0.000701	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SMO—bone cancer	0.000643	0.000694	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SMO—bone cancer	0.000635	0.000686	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ENO2—bone cancer	0.000615	0.000665	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PTGS2—bone cancer	0.000607	0.000656	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ATF1—bone cancer	0.000606	0.000654	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SMO—bone cancer	0.000601	0.000649	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CYP3A4—bone cancer	0.000596	0.000643	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GNA11—bone cancer	0.000594	0.000641	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SMO—bone cancer	0.000591	0.000638	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL3—bone cancer	0.000591	0.000638	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GNA11—bone cancer	0.000588	0.000635	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GNA11—bone cancer	0.000581	0.000627	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—DHFR—bone cancer	0.000571	0.000617	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ATF1—bone cancer	0.000552	0.000596	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GNA11—bone cancer	0.000549	0.000593	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ATF1—bone cancer	0.000547	0.00059	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GNA11—bone cancer	0.000541	0.000584	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ATF1—bone cancer	0.00054	0.000583	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL3—bone cancer	0.000538	0.000581	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GNA11—bone cancer	0.000534	0.000576	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL3—bone cancer	0.000533	0.000576	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—KIT—bone cancer	0.000529	0.000571	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL3—bone cancer	0.000526	0.000568	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SMO—bone cancer	0.000525	0.000567	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ATF1—bone cancer	0.000511	0.000552	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GSTP1—bone cancer	0.000509	0.00055	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	0.000505	0.000545	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ATF1—bone cancer	0.000503	0.000543	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL3—bone cancer	0.000498	0.000538	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—BRAF—bone cancer	0.000497	0.000537	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL3—bone cancer	0.00049	0.000529	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SMO—bone cancer	0.000488	0.000527	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CYP3A4—bone cancer	0.000484	0.000522	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—EGFR—bone cancer	0.000482	0.000521	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GNA11—bone cancer	0.00048	0.000519	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IGF1R—bone cancer	0.000475	0.000513	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFBR2—bone cancer	0.00046	0.000497	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	0.000456	0.000492	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFBR2—bone cancer	0.00045	0.000486	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ATF1—bone cancer	0.000446	0.000482	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GNA11—bone cancer	0.000446	0.000482	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL3—bone cancer	0.000435	0.00047	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IGF1R—bone cancer	0.000433	0.000468	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IGF1R—bone cancer	0.000429	0.000463	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	0.000426	0.00046	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IGF1R—bone cancer	0.000424	0.000457	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	0.000419	0.000453	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MDM2—bone cancer	0.000417	0.00045	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ATF1—bone cancer	0.000415	0.000448	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TP53—bone cancer	0.000415	0.000448	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GSTP1—bone cancer	0.000414	0.000447	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL3—bone cancer	0.000405	0.000437	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF1R—bone cancer	0.000401	0.000433	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF1R—bone cancer	0.000394	0.000426	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TP53—bone cancer	0.000387	0.000418	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	0.000372	0.000402	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—JUN—bone cancer	0.000362	0.000391	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP9—bone cancer	0.000352	0.000381	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF1R—bone cancer	0.00035	0.000378	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	0.000346	0.000374	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—KIT—bone cancer	0.000345	0.000372	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF1R—bone cancer	0.000326	0.000352	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—BRAF—bone cancer	0.000324	0.00035	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TP53—bone cancer	0.000315	0.00034	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—KIT—bone cancer	0.000314	0.000339	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—EGFR—bone cancer	0.000314	0.000339	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—KIT—bone cancer	0.000311	0.000336	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—KIT—bone cancer	0.000307	0.000332	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—BRAF—bone cancer	0.000295	0.000319	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—BRAF—bone cancer	0.000292	0.000316	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—KIT—bone cancer	0.000291	0.000314	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—BRAF—bone cancer	0.000289	0.000312	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—EGFR—bone cancer	0.000286	0.000309	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—KIT—bone cancer	0.000286	0.000309	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—EGFR—bone cancer	0.000285	0.000308	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—EGFR—bone cancer	0.000283	0.000306	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—EGFR—bone cancer	0.00028	0.000302	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—BRAF—bone cancer	0.000273	0.000295	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MDM2—bone cancer	0.000271	0.000293	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—BRAF—bone cancer	0.000269	0.00029	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—EGFR—bone cancer	0.000265	0.000286	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—bone cancer	0.000264	0.000285	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—EGFR—bone cancer	0.000261	0.000281	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—KIT—bone cancer	0.000254	0.000274	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MDM2—bone cancer	0.000247	0.000267	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MDM2—bone cancer	0.000245	0.000265	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MDM2—bone cancer	0.000242	0.000261	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TP53—bone cancer	0.000239	0.000258	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—BRAF—bone cancer	0.000239	0.000258	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—KIT—bone cancer	0.000236	0.000255	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—JUN—bone cancer	0.000236	0.000255	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—EGFR—bone cancer	0.000231	0.00025	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—bone cancer	0.00023	0.000248	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MDM2—bone cancer	0.000229	0.000247	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MDM2—bone cancer	0.000225	0.000243	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—BRAF—bone cancer	0.000222	0.00024	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—EGFR—bone cancer	0.000215	0.000232	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—JUN—bone cancer	0.000215	0.000232	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—bone cancer	0.000214	0.000232	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—JUN—bone cancer	0.000213	0.00023	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—JUN—bone cancer	0.00021	0.000227	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—bone cancer	0.000209	0.000226	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—bone cancer	0.000207	0.000224	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—bone cancer	0.000205	0.000221	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MDM2—bone cancer	0.0002	0.000216	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—JUN—bone cancer	0.000199	0.000215	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—JUN—bone cancer	0.000196	0.000211	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—bone cancer	0.000194	0.000209	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—bone cancer	0.000191	0.000206	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MDM2—bone cancer	0.000186	0.000201	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EGFR—bone cancer	0.000185	0.0002	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—JUN—bone cancer	0.000174	0.000188	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—bone cancer	0.000169	0.000183	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EGFR—bone cancer	0.000169	0.000183	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EGFR—bone cancer	0.000167	0.000181	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EGFR—bone cancer	0.000165	0.000179	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—JUN—bone cancer	0.000162	0.000175	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—bone cancer	0.000157	0.00017	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EGFR—bone cancer	0.000156	0.000169	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—bone cancer	0.000156	0.000168	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EGFR—bone cancer	0.000154	0.000166	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—bone cancer	0.000142	0.000153	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—bone cancer	0.000141	0.000152	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—bone cancer	0.000139	0.00015	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EGFR—bone cancer	0.000137	0.000148	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—bone cancer	0.000131	0.000142	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—bone cancer	0.000129	0.00014	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EGFR—bone cancer	0.000127	0.000137	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—bone cancer	0.000115	0.000124	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—bone cancer	0.000107	0.000115	CbGpPWpGaD
